Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Biogen CEO Resigns!!

View:

Post by Jumpinjackfast on May 03, 2022 9:10am

Biogen CEO Resigns!!

That's what happens will you fail .

137

Comment

Comment by BottomBroker on May 03, 2022 11:01am

They're also apparently slashing the amount of money they're putting into Aduhelm. Maybe that'll free up some cash to put into a JV with a drug that might actually work? Like PMN310? A guy can dream, right?

115

Comment

Comment by azzymaa on May 03, 2022 12:50pm

Company is diluting Capital like it's no big deal. Pathetic BOD.

Comment

Comment by M101 on May 03, 2022 2:49pm

lol, it's practically a done deal already! "Noted Vounatsos: I will be leaving at a time of promise for Biogen..."

104

Comment

Comment by BottomBroker on May 03, 2022 3:05pm

See, I knew it. He's trying to send subliminal messages. Much like the neighbor's dog did to Son of Sam.

Comment

Comment by retiredcop on May 03, 2022 3:19pm

Biogen is double-dipping into a 2020 collaboration with Scribe Therapeutics, exercising its option for an additional neurological disease target in gene therapy using the biotech's CRISPR technology. The announcement adds a second target to the partnership first disclosed in 2020 to develop a new therapy for amyotrophic lateral ...more

122

Comment

ProMIS Neurosciences Inc